Evaluation Studies
Journal Article
Add like
Add dislike
Add to saved papers

Efficacy of a dynamic collimator for overranging dose reduction in a second- and third-generation dual source CT scanner.

European Radiology 2017 September
OBJECTIVES: The purpose of this study was to assess the efficacy of the renewed dynamic collimator in a third-generation dual source CT (DSCT) scanner and to determine the improvements over the second-generation scanner.

METHODS: Collimator efficacy is defined as the percentage overranging dose in terms of dose-length product (DLP) that is blocked by the dynamic collimator relative to the total overranging dose in case of a static collimator. Efficacy was assessed at various pitch values and different scan lengths. The number of additional rotations due to overranging and effective scan length were calculated on the basis of reported scanning parameters. On the basis of these values, the efficacy of the collimator was calculated.

RESULTS: The second-generation scanner showed decreased performance of the dynamic collimator at increasing pitch. Efficacy dropped to 10% at the highest pitch. For the third-generation scanner the efficacy remained above 50% at higher pitch. Noise was for some pitch values slightly higher at the edge of the imaged volume, indicating a reduced scan range to reduce the overranging dose.

CONCLUSIONS: The improved dynamic collimator in the third-generation scanner blocks the overranging dose for more than 50% and is more capable of shielding radiation dose, especially in high pitch scan modes.

KEY POINTS: • Overranging dose is to a large extent blocked by the dynamic collimator • Efficacy is strongly improved within the third-generation DSCT scanner • Reducing the number of additional rotations can reduce overranging with increased noise.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app